CRISPR/Cas9 Monoclonal Antibody [7A9-3A3]-0.1ml IQ651 from ImmuQuest Ltd.

Product Specs
ItemCRISPR/Cas9 Monoclonal Antibody [7A9-3A3]-0.1ml
CompanyImmuQuest Ltd.
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberIQ651
Quantity0.1mg
Concentration1mg/ml
FormatPurified antibody (from supernatant) containing PBS + 0.09% sodium azide
ReactivityStreptococcus pyogene
IsotypeIgG1 kappa
HostMouse
ImmunogenThis antibody was raised against a recombinant protein within the N-terminal region of Streptococcus pyogene Cas9
PurityProtein A
Clone7A9-3A3
ApplicationsIB, IP, ICC/IF, WB
ClonalityMonoclonal
TargetCRISPR/Cas9

Myeloma/fusion partners: X63.Ag8-653

Springboard Business Centre

Ellerbeck Way Stokesley Business Park

N.Yorkshire TS9 5JZ

United Kingdom

(1) Base-edited CAR T cells for combinational therapy against T cell malignanciesLeukemiaDecember 1, 2021Georgiadis C, Rasaiyaah J, Gkazi SA, Preece R, Etuk A, Christi A, Qasim W.

(2) Regulation of telomere homeostasis and genomic stability in cancer by N ⁶-adenosine methylation (m⁶A)Science advancesJuly 1, 2021Lee JH, Hong J, Zhang Z, de la Peña Avalos B, Proietti CJ, Deamicis AR, Guzmán G P, Lam HM, Garcia J, Roudier MP, et al.

(3) Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALSCommunications biologyMarch 25, 2021Deng HX, Zhai H, Shi Y, Liu G, Lowry J, Liu B, Ryan ÉB, Yan J, Yang Y, Zhang N, et al.

(4) Precise and broad scope genome editing based on high-specificity Cas9 nickasesNucleic acids researchJanuary 25, 2021Wang Q, Liu J, Janssen JM, Le Bouteiller M, Frock RL, Gonçalves MAFV.

(6) Production of TRPM4 knockout cell line using rat cardiomyocyte H9c2MethodsXJanuary 1, 2021Wang C, Maeda M, Chen J, Wang M, Naruse K, Takahashi K.

(7) Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domainNucleic acids researchOctober 9, 2020Ma S, Wang X, Hu Y, Lv J, Liu C, Liao K, Guo X, Wang D, Lin Y, Rong Z.

(8) High-efficiency nonhomologous insertion of a foreign gene into the herpes simplex virus genomeThe Journal of general virologySeptember 1, 2020Gong Y, Bi Y, Li Z, Li Y, Yao Y, Long Q, Pu T, Chen C, Liu T, Dong S, et al.

(9) Disc-associated proteins mediate the unusual hyperstability of the ventral disc in Giardia lambliaJournal of cell scienceAugust 27, 2020Nosala C, Hagen KD, Hilton N, Chase TM, Jones K, Loudermilk R, Nguyen K, Dawson SC.

(10) Hepatic stellate cell-specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosisThe Journal of experimental medicineJune 1, 2020Lee EJ, Hwang I, Lee JY, Park JN, Kim KC, Kim I, Moon D, Park H, Lee SY, Kim HS, et al.

(11) Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 componentsGene therapyMay 1, 2020Maggio I, Zittersteijn HA, Wang Q, Liu J, Janssen JM, Ojeda IT, van der Maarel SM, Lankester AC, Hoeben RC, Gonçalves MAFV.

(12) Macrophages show higher levels of engulfment after disruption of cis interactions between CD47 and the checkpoint receptor SIRPαJournal of cell scienceMarch 6, 2020Hayes BH, Tsai RK, Dooling LJ, Kadu S, Lee JY, Pantano D, Rodriguez PL, Subramanian S, Shin JW, Discher DE.

(13) Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editingNature communicationsJanuary 24, 2020Li K, Liu Y, Cao H, Zhang Y, Gu Z, Liu X, Yu A, Kaphle P, Dickerson KE, Ni M, et al.

(14) RNAi-mediated control of CRISPR functionsTheranosticsJanuary 1, 2020Huang X, Chen Z, Liu Y.

(15) Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular systemNucleic acids researchOctober 10, 2019Josipović G, Tadić V, Klasić M, Zanki V, Bečeheli I, Chung F, Ghantous A, Keser T, Madunić J, Bošković M, et al.

(19) Determination of local chromatin interactions using a combined CRISPR and peroxidase APEX2 systemNucleic acids researchMay 21, 2019Qiu W, Xu Z, Zhang M, Zhang D, Fan H, Li T, Wang Q, Liu P, Zhu Z, Du D, et al.

(20) A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9CellMay 2, 2019Maji B, Gangopadhyay SA, Lee M, Shi M, Wu P, Heler R, Mok B, Lim D, Siriwardena SU, Paul B, et al.

CRISPR/Cas9 Monoclonal Antibody [7A9-3A3]-0.1ml